Form 4: Procept BioRobotics EVP, CFO Kevin Waters Sells Shares to Cover Tax Obligations

Kevin Waters, EVP and CFO of Procept BioRobotics Corp, sold 3,662 shares of common stock on March 6, 2025, to cover tax withholding obligations related to vesting Restricted Stock Units.

Summary

• On March 6, 2025, Kevin Waters, the EVP and CFO of Procept BioRobotics Corp, sold 3,662 shares of the company's common stock.
• The sale was executed at a weighted average price of $61.31 per share.
• The transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
• Following the transaction, Waters directly owns 108,724 shares of Procept BioRobotics Corp.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports a stock sale for tax purposes, which is a common practice.

Industry Context

Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This filing indicates that a high-ranking executive sold shares, which is not necessarily indicative of the company's performance but rather a personal financial decision related to tax obligations.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact as it is for tax purposes.

Key Dates